Metraipolis › archive › dc_a4fa714be584
Ligand-directed oral lipidic nanoplatform enables sustained ferroptosis and immune reprogramming via multivalent transporter-mediated metronomic delivery — Europe PMC PMID:41510171
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41510171
- DOI
- 10.7150/thno.124189
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-07T03:47:55.829Z
- SHA-256 of the archived text
cb41be287e05a310eebaf6b957c12c35778a99003bb407d62291d88e7fc9d90e- Stable URL of this page
https://metraipolis.com/documento/dc_a4fa714be584
How to cite
Ligand-directed oral lipidic nanoplatform enables sustained ferroptosis and immune reprogramming via multivalent transporter-mediated metronomic delivery — Europe PMC PMID:41510171 — Europe PMC (en), https://europepmc.org/article/MED/41510171 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_a4fa714be584 (Metraipolis archive dc_a4fa714be584, sha256 cb41be287e05a310eebaf6b957c12c35778a99003bb407d62291d88e7fc9d90e)
BibTeX
@misc{dca4fa714be584,
title = {Ligand-directed oral lipidic nanoplatform enables sustained ferroptosis and immune reprogramming via multivalent transporter-mediated metronomic delivery — Europe PMC PMID:41510171},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41510171},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_a4fa714be584; sha256 cb41be287e05a310eebaf6b957c12c35778a99003bb407d62291d88e7fc9d90e},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41510171. Agents can read the archived copy with the MCP tool read_document.